T cells engineered against Dickkopf-1-A2 complex can be used to treat HLA-A2+ solid and hematologic cancers

Journal:

Nature Communications

Published:

2026-02-16

DOI:

10.1038/s41467-026-69621-8

Affiliations:

7

Authors:

16

Go to article

Institutions	Authors	Share
Houston Methodist Neal Cancer Center, United States of America (USA)	7.500000	0.47
Houston Methodist Research Institute, United States of America (USA)	7.500000	0.47
Houston Methodist Hospital, United States of America (USA)	1.000000	0.06

Interested in Oncology and Carcinogenesis?